Validation of RP-HPLC method for determination of filgrastim in pharmaceutical formulations
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: TONIC - RIBARSKA, Jasmina (Faculty of Pharmacy, University Ss Cyril and Methodius, Skopje, Macedonia)
- Co-author(s): Batkovska-Borozanova, Irina (Faculty of Pharmacy, University Ss Cyril and Methodius, SKOPJE, Macedonia)
Trajkovic-Jolevska, Suzana (Faculty of Pharmacy, University Ss Cyril and Methodius, SKOPJE, Macedonia)
Filgrastim is a human granulocyte colony-stimulating factor"š which belongs to a family of cytokines. It is produced by recombinant DNA technology in genetically engineered Escherihia coli cells. Filgrastim has a bilogical action essential for proliferation and differentiation of hematopoetic and progenitor cells.Filgrastim is used for decreasing.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.